Author: Deal Street Asia Online News

Saudi Arabia raises $12.35b from Aramco share sale after increasing offer

Saudi Arabia raised a total of $12.35 billion from selling more shares in Aramco after increasing the offering in the world’s most valuable oil company, a document seen by Reuters showed. The success of the share sale and additional proceeds will help further fuel Saudi Arabia’s ambitions to invest in new industries and wean its… Continue reading Saudi Arabia raises $12.35b from Aramco share sale after increasing offer

Zhipu AI invests in SiliconFlow and 42 other Greater China deals worth over $360m

URTOPIA Shenzhen 10 A Guangyuan Hesheng Fund, Easy Click Worldwide Network Technology, Tongxiang City Jintong Fund Kongho Fund, Brizan Ventures, DCM Ventures, Gao Bingqiang (Individual Investor) Consumer Products Micro-Mobility MoonBiotech Guangzhou 41.3 C+ SDIC JULI (affiliated with State Development and Investment Group) Biotech Biotech MingCeler Guangzhou Pre-A Guangzhou Finance Holdings Group Biotech Biotech Senboelec Suzhou… Continue reading Zhipu AI invests in SiliconFlow and 42 other Greater China deals worth over $360m

Asia Digest: WeBank sets up tech HQ in Hong Kong; Fave gets MAS nod for MPI licence 

WeBank, a digital bank founded in Shenzhen, has established its technology company headquarters in Hong Kong while Fave Singapore announced that it has received an in-principle approval from the Monetary Authority of Singapore for a Major Payment Institution (MPI) Licence. WeBank to establish technology company headquarters in HK WeBank, a digital bank founded in Shenzhen,… Continue reading Asia Digest: WeBank sets up tech HQ in Hong Kong; Fave gets MAS nod for MPI licence 

India’s Emcure Pharma jumps 35% in debut trade at $223m valuationBain Capital-backed Emcure is the first drugmaker to go public in 2024.

Indian drugmaker Emcure Pharmaceuticals’ shares rose 34.9% in debut trade on Wednesday, beating analysts’ estimates and valuing the company at 18.64 billion rupees ($223.3 million), as its strong presence in women’s healthcare and HIV treatments drew investors. In an IPO market where over 100 companies raised more than $4.6 billion so far this year, Bain Capital-backed Emcure is the first drugmaker to go public in 2024.… Continue reading India’s Emcure Pharma jumps 35% in debut trade at $223m valuationBain Capital-backed Emcure is the first drugmaker to go public in 2024.

China’s Cirrus Aircraft raises $192m in Hong Kong IPO

Chinese-owned Cirrus Aircraft has priced its shares at HK$27.50 ($3.52) each to raise $192 million in its Hong Kong initial public offering, a source with direct knowledge of the matter said on Wednesday. The source could not be identified since they are discussing non-public information. Cirrus Aircraft did not immediately respond to a request for comment from Reuters. According to its regulatory filings, the U.S-based… Continue reading China’s Cirrus Aircraft raises $192m in Hong Kong IPO

Shares of Kokusai Electric fall 9% in Tokyo following KKR share sale report

Shares in Kokusai Electric fell 9% in early Tokyo trading on Wednesday, a day after Reuters reported private equity firm KKR plans to cut its stake in the Japanese chip equipment manufacturer. KKR plans to sell roughly half of its 43% stake in Kokusai to investors, Reuters reported late on Tuesday, cashing in after a… Continue reading Shares of Kokusai Electric fall 9% in Tokyo following KKR share sale report

Two Chinese companies sink 15% in HKEX debut as mood remains negative

Two Chinese companies sunk by 15% in their Hong Kong initial public offerings (IPO) debuts on Tuesday, while a small Chinese petroleum refiner soared nearly 30% as sentiment towards new share sales in the city remains volatile. Chenqi Technology opened down 14.3% and Shanghai Voicecomm sunk 15.4% in early trade on Tuesday. Ruichang International, which… Continue reading Two Chinese companies sink 15% in HKEX debut as mood remains negative